Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clene (CLNN) Cash & Equivalents (2020 - 2025)

Clene (CLNN) has 6 years of Cash & Equivalents data on record, last reported at $7.9 million in Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 45.89% year-over-year to $7.9 million; the TTM value through Sep 2025 reached $7.9 million, down 45.89%, while the annual FY2024 figure was $12.2 million, 57.83% down from the prior year.
  • Cash & Equivalents reached $7.9 million in Q3 2025 per CLNN's latest filing, up from $7.3 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $63.0 million in Q2 2021 and bottomed at $7.3 million in Q2 2022.
  • Average Cash & Equivalents over 5 years is $26.4 million, with a median of $18.4 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: soared 814.6% in 2021, then tumbled 88.49% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $50.3 million in 2021, then crashed by 63.55% to $18.3 million in 2022, then surged by 57.22% to $28.8 million in 2023, then tumbled by 57.83% to $12.2 million in 2024, then crashed by 34.8% to $7.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $7.9 million in Q3 2025, $7.3 million in Q2 2025, and $9.8 million in Q1 2025.